The company will use the funds to increase the adoption of its new offering, Sage, across healthcare providers, payers and care management organizations.
The partners will develop and clinically validate an AI tool that integrates into EHRs to accelerate the diagnosis of hypophosphatasia, a rare genetic bone disorder.
Kidd's company will use 1,000 Bitcoin and additional cash to acquire the interest, and the former Ripple chief risk officer will become CEO and chairman of the board.